Federal Court issues two interlocutory decisions in section 8 pregabalin case

Published date06 November 2019
Subject MatterPatents,Section 8,Pfizer,Interlocutory Orders,Pharmaceutical Patents,Canada,Patent Infringement,Patented Medicines
AuthorKatie Lee
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT